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Actinomadura sp. R39 produces an exocellular DD-
peptidase/penicillin-binding protein (PBP) whose pri-
mary structure is similar to that of Escherichia coli
PBP4. It is characterized by a high -lactam-binding
activity (second order rate constant for the acylation of
the active site serine by benzylpenicillin: k2/K  300
mM1s1). The crystal structure of the DD-peptidase
from Actinomadura R39 was solved at a resolution of 1.8
Å by single anomalous dispersion at the cobalt reso-
nance wavelength. The structure is composed of three
domains: a penicillin-binding domain similar to the pen-
icillin-binding domain of E. coli PBP5 and two domains
of unknown function. In most multimodular PBPs, ad-
ditional domains are generally located at the C or N
termini of the penicillin-binding domain. In R39, the
other two domains are inserted in the penicillin-binding
domain, between the SXXK and SXNmotifs, in a manner
similar to “Matryoshka dolls.” One of these domains is
composed of a five-stranded -sheet with two helices on
one side, and the other domain is a double three-
stranded -sheet inserted in the previous domain. Addi-
tionally, the 2.4-Å structure of the acyl-enzyme complex
of R39 with nitrocefin reveals the absence of active site
conformational change upon binding the -lactams.
Cell wall assembly is catalyzed by a series of active-site
serine DD-peptidases, known as penicillin-binding proteins
(PBPs).1 These enzymes catalyze the final steps in the synthe-
sis of cell wall peptidoglycan, a highly cross-linked mesh that
surrounds the bacteria and protects them from osmotic shock
and lysis. They constitute the lethal targets of penicillins and
more generally of -lactam antibiotics, which exhibit a rough
structural analogy with the PBP peptide substrates, i.e. the
D-alanyl-D-alanine C termini of peptidoglycan stem peptides.
-Lactams acylate the active site serine of the penicillin-bind-
ing domain of PBPs and form a rather stable acyl-enzyme
devoid of transpeptidase activity (1).
Multiple PBPs, from three in Neisseria meningiditis to
twelve in Escherichia coli, are bound to the cytoplasmic mem-
brane of all bacteria. These PBPs can be divided into two
groups: the high molecular mass PBPs, which are multimodu-
lar enzymes containing a DD-transpeptidase domain associ-
ated either with a transglycosylase domain or with a domain of
unknown function and the low molecular mass PBPs, which act
mainly as DD-transpeptidases or DD-carboxypeptidases (2, 3).
Low molecular mass PBPs are further divided into classes A, B,
and C according to their sequences (1, 4). Structural informa-
tion on class A and class B low molecular mass PBPs has been
made available through crystal structures determination of
E. coli PBP5 (5) and the Streptomyces K15 DD-peptidase (K15)
(6), two representatives of the class A, and of the Streptomyces
R61 DD-transpeptidase-carboxypeptidase (R61) (7), a well
studied enzyme representative of class B. The overall fold of
PBP5 is that of class A -lactamases with a C-terminal exten-
sion domain, whereas R61 is similar to class C -lactamases.
Despite the absence of crystal structure of class C low molecu-
lar mass PBPs, similarities with class A -lactamases have
been highlighted. Compared with the class A -lactamase
structures, these proteins exhibit an additional domain of
about 200 residues inserted between the SXXK and the SXN
conserved motifs characteristic of the penicillin-binding do-
main (8, 9).
The Actinomadura sp. strain R39 DD-peptidase (R39) is a
class C low molecular mass PBP that is related to E. coli PBP4
(8), Bacillus subtilis PBP4a (10, 11), and Neisseria gonorrhoeae
PBP3 (12). The members of this class of PBPs exhibit medium
to high sensitivity to -lactams, DD-carboxypeptidase, and
transpeptidase activity. They also exhibit a so-called endopep-
tidase activity, i.e. they can release a C-terminal residue bear-
ing a large and complex side chain, which is in fact a facet of
their carboxypeptidase activity. Moreover, in contrast to most
other PBPs, which are strongly anchored in the membrane,
class C low molecular mass PBPs are soluble or loosely bound
to the membrane via an amphiphilic C-terminal helix (10, 13).
Under laboratory growth conditions E. coli PBP4 appears to be
dispensable, and similar results were found for B. subtilis
PBP4a and N. gonorrhoeae PBP3.
In addition to the low molecular mass PBPs, a few high
molecular mass PBPs have been crystallized: Streptococcus
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pneumoniae PBP2x (14), Staphylococcus aureus PBP2a (15),
and Enterococcus faecium PBP5 (PBP5fm) (16), three class B
high molecular mass PBPs involved in determining the level of
resistance to -lactam encountered in these bacteria. The crys-
tal structure of R39 is the first structure of a class C low
molecular mass PBP and reveals special structural features
that characterize this class of PBPs.
EXPERIMENTAL PROCEDURES
Purification and Crystallization—R39 has been expressed and puri-
fied as described previously (8). Crystals were grown at 20 °C by hang-
ing drop vapor diffusion. Native crystals were obtained by mixing 2.5 l
of 25 mg ml1 protein solution (containing 5 mM MgCl2 and 0.1 M Tris)
and 2.5 l of well solution per drop (containing 1.5 M ammonium sulfate
and 0.1 M Tris, pH 8). The crystallization conditions were optimized by
a search around these conditions and by testing several additives,
including different chloride salts. Crystals of the Co2 derivative were
prepared by mixing 2.5 l of 25 mg ml1 protein solution (containing 5
mM MgCl2 and 0.02 M Tris), 2 l of well solution (containing 2.0 M
ammonium sulfate and 0.1 M MES, pH 6), and 0.5 l of 0.1 M CoCl2
solution. Nitrocefin-soaked crystal were prepared using the same con-
ditions and then transferred to 2 l of well solution containing nitroce-
fin (1 mM) for 14 h. Before data collection, crystals were cryoprotected
with 100% glycerol.
Data Collection, Phase Determination, and Structure Refinement—
Native data were collected at 100 K on an ADSC Quantum 4R charge-
coupled device detector at beamline ID29 at the European Synchrotron
Radiation Facility (ESRF, Grenoble, France). SAD data and nitrocefin-
soaked crystal data were collected at 100 K on a MAR charge-coupled
device detector at beamline BM30a at ESRF. All data were processed
and scaled using Mosflm (17) and CCP4 (18). The structure was solved
by a SAD experiment at the peak wavelength of Co2 K-edge (1.605 Å).
The eighteen Co2 sites were found with Solve (19). Phasing with
Resolve (20) produced a clearly interpretable electron density map,
from which a complete model could be built using Turbo-Frodo (21).
This monomer was used as a search model for molecular replacement,
with native data. The four monomers in the asymmetric unit were
found using AMoRe (22). Subsequent refinement was carried out using
CNS (23), and manual model fitting was done with Turbo-Frodo. The
four monomers were refined individually. The figures were prepared
with Molscript (24), Bobscript (25), and Raster3D (26).
RESULTS
Structure Determination—R39 is a soluble 538-amino acid
protein, as deduced from DNA sequence analysis, including a
49-amino acid signal peptide. The tracing of the resulting 489-
amino acid R39 molecule in the electron density maps showed
that the 23-amino acid C-terminal peptide (467–489) is miss-
ing. Subsequent mass spectrometry analyses indicated that the
purified enzyme contained 466 residues prior to crystallization.
Because a production system of R39 in E. coli was not avail-
able and selenomethionine-substituted protein could not be
obtained, a search for the presence of anomalous scattering
ions, firstly added to enhance crystal growth, was monitored by
using a fluorescence detector available at the BM30a beamline
at ESRF. A strong fluorescence peak was observed with a
crystal grown in presence of Co2. Thus the use of Co2 ions in
the crystallization conditions facilitated the structure determi-
nation by single anomalous diffraction at the cobalt resonance
wavelength (Table I). R39 crystallizes in space group P21 (a 
104.56 Å; b  94.37 Å; c  106.96 Å;   94.05°) with four
molecules and eighteen Co2 ions in the asymmetric unit (Fig.
1A). The crystallographic environment is similar for molecules
A and D and molecules B and C but is different for both pairs.
Five Co2 ions are found in molecules A and D, whereas only
four are found in molecules B and C. Each Co2 ion is ligated by
at least one histidine and one aspartic or glutamic acid resi-
dues. In molecule A, a Co2 ion is located between His282 and
Glu466 of a crystallographic symmetry-related molecule of mol-
ecule A. The same situation arises for molecule D. Because the
crystallographic environment is different for molecules B and
C, the absence of cobalt near residue 466 results in a disordered
464–466 segment with elevated temperature factors for resi-
dues 464 and 465 and loss of interpretable density for residue
466. The root mean square deviation between any two mole-
cules of the asymmetric unit is between 0.35 and 0.40 Å. The
final structure has been refined at 1.8 Å against data collected
from a crystal grown in slightly different conditions in the
absence of Co2. In this refined structure, four Mg2 ions are
present in the asymmetric unit in sites of four of the 18 Co2
ions. Two of these Mg2 ions are found in molecule A and two
in molecule D.
Overall Structure—Topologically, R39 is composed of three
distinct domains. The penicillin-binding domain consists of
residues 1–65 and 285–466 (Fig. 1, B and C). The second
domain (domain II) comprises residues 66–165 and 237–284
and corresponds to an insertion at the beginning of helix 4
between the motifs SXXK and SXN, two usual motifs of the
PBPs active site. The third domain (domain III) is a subdomain
TABLE I
Data collection, phasing and refinement statistics
Data set Co2 Native Nitrocefin-soaked
PDB code 1W8Q 1W79 1W8Y
Wavelength (Å) 1.605 0.9763 0.970
Resolution range (Å)a 50–2.85 50–1.8 50–2.4
(3.0–2.85) (1.91–1.8) (2.55–2.4)
Unique reflections 47,856 187,527 69,694
Redundancya 13.3 (5.5) 3.6 (3.6) 2.9 (2.53)
Completeness (%)a 98.0 (86.7) 98.5 (95.6) 86.6 (80.5)
I/ (I)a 20.7 (2.7) 11.7 (3.9) 9.5 (2.2)
Rsym (%)
a 15.3 (71) 9.7 (46) 10.1 (54)
Refinement
Resolution range (Å) 20–2.85 20–1.8 20–2.4
 Cutoff 2 2 2
Rcryst/Rfree (%) 19.7/24.4 21.4/24.0 22.7/28.6
Number of protein atoms 13394 13,394 13,394
Number of ions 18 Co2 4 Mg2 4 Mg2
Number of water molecules 80 1781 829
Average B-factors (Å2)
Protein 41.9 22.0 43.5
Nitrocefin 40.0
Water 52.5 34.3 45.3
Root mean square deviations
Bond lengths (Å) 0.006 0.005 0.007
Bond angles (°) 1.2 1.3 1.3
a Statistics for the highest resolution shell are given in parentheses.
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inserted in domain II and consists of residues 166–236. Each
domain possesses a -sheet that is oriented approximately at
right angle from the -sheets of the other two domains.
Penicillin-binding Domain—The penicillin-binding domain
shares its overall fold with other penicillin-binding proteins
and the serine -lactamases: the R39 active site is located in an
extended groove between a five-stranded anti-parallel -sheet
and a cluster of -helices. The root mean square deviations
with the corresponding domains of other PBPs range between
2.2 and 2.8 Å (Table II). Structure-based alignments of these
domains reveal significant structural differences. The struc-
tures providing the greatest degree of folding similarity are
those of E. coli PBP5 and class A -lactamases, with some
major differences. The first difference is the replacement of the
-lactamase variable loop inserted before helix 4 by the 220-
amino acid peptide corresponding to domains II and III. A loop
of R39 domain II extends near the active site, reminiscent of
the variable loop in -lactamases, but the two loops are struc-
turally different. The second difference is the absence of the
-lactamase -like loop defining the bottom of the active site.
In this region, the 343–353 segment is folded like its counter-
part in PBP5. The third difference is the conformation of the
residues surrounding helix 10 in a region situated above the
active site (residues 381–408).
The residues involved in the enzymatic activity and defining
the active site correspond to the three conserved motifs found in
TABLE II
Root mean square deviations between the R39 penicillin-binding
domain and the corresponding domains of other PBPs
Enzyme K15 PBP5 R61
Root mean square deviation (Å) 2.23 2.32 2.84
Number of aligned C atoms 187 185 192
FIG. 1. Structure of R39. A, asymmetric unit cell representation. Co2 ions are shown as small brown spheres. Crystallographic environment
is similar for molecules A and D and molecules B and C but different for both pairs; B, overall structure of R39 shown as a ribbon diagram. The
penicillin-binding domain is green, domain II is yellow and brown, and domain III is blue. The position of the active site serine is indicated by a
red‘S‘; C, active site of R39. Secondary structure elements of the penicillin-binding domain have been labeled in accordance with the labeling
scheme of class A -lactamases. Ser49 and Lys52 form the first motif SXXK characteristic of the penicillin-binding proteins active site. Ser298 and
Asn300 form the second motif SXN, and the third motif, KTGT, consists of Lys410, Thr411, Gly412, and Thr413.
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PBPs and class A -lactamases: Ser49-Xaa-Xaa-Lys52 (motif 1),
Ser298-Xaa-Asn300 (motif 2), and Lys410-Thr411-Gly412-Thr413
(motif 3). As in other PBPs, a dense hydrogen bond network
prevails in the R39 active site, with a water molecule in the
oxyanion hole formed by the backbone nitrogens of Ser49 and
Thr413. In the upper region of the active site, although the su-
perposition of most PBP backbones does not fit in the surround-
ings of helix 10, a threonine is frequently observed at the exact
position of Thr393 (Thr199 in K15, Thr526 in PBP2x, Thr526 in
PBP2a, Thr603 in PBP5fm, and Thr216 in the Streptomyces albus
G class A -lactamase (SaG) (27)). Thr393 O is hydrogen-bonded
to Thr411 O and contributes to the hydrogen bond network that
strengthens the active site. A distinctive feature of R39 is a
specific pocket observed in the bottom of the active site and
mainly defined by residues Trp139, Asp142, Tyr147, three residues
belonging to domain II, and Arg351 and Met414, two residues of
the penicillin-binding domain. This characteristic could prove
useful in the development of specific -lactam antibiotics with a
high affinity for R39, as developed for the R61 DD-peptidase (28).
Acylation with -Lactams—R39 is highly sensitive to -lac-
tams (k2/K  2600 mM
1 s1 for nitrocefin), and deacylation
occurs at a very low rate (k3  1.5  10
6 s1) (3), a favorable
situation for the accumulation of an acyl-enzyme. After soaking
in nitrocefin, the four molecules present in the asymmetric unit
are acylated. The electron density of the R39 active site unam-
biguously reveals a covalent acyl-enzyme with nitrocefin (Fig. 2).
The dihydrothiazolidine ring and the carboxylate are well de-
fined, and the electron density is continuous between the active
site serine hydroxyl group and the -lactam carbonyl group.
There is no density for the R2 substituent of nitrocefin. Depar-
ture of the C3 substituent after electronic rearrangement upon
opening of the -lactam ring has been observed in acyl-enzyme
complexes of R61 and PBP2x with cephalosporins (29, 30), but
not in the acyl-nitrocefin-PBP2a structure (15). Apart from the
FIG. 2. Interaction between R39 and nitrocefin. A, structure of nitrocefin; B, nitrocefin-R39 acyl-enzyme structure. Stereo view of a Fobs 
Fcalc electron density omit map calculated without the nitrocefin molecule, contoured at 2. Nitrocefin is magenta, the penicillin-binding domain
is green, and domain II is yellow. The side chain of nitrocefin fills a pocket formed by Trp139, Asp142, Tyr147, Arg351, and Met414; C, comparison
between the structures of the R39 apo-enzyme and the nitrocefin acyl-enzyme. Apo-enzyme is gray, and nitrocefin acyl-enzyme is colored as in B.
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R2 substituent, the position of nitrocefin in the active site is
similar to that observed with PPB2a. The amide group in the
nitrocefin side-chain hydrogen bonds to Asn300 O1 and to the
backbone carbonyl of Thr413, the -lactam carbonyl oxygen being
located in the oxyanion hole. The nitrocefin carboxylate is hydro-
gen bonded to Thr411 and Thr413, as observed in many acyl-PBPs
complexes. It is noteworthy that, among 25 class C lowmolecular
mass PBPs sequences aligned with R39 in a Blast search (31),
Arg397 is one of the few strictly conserved residues. Its position in
helix 10 is equivalent to the position of Arg220 in SaG. Owing to
the 10 position, which is slightly different in class A -lactama-
ses and R39, the distance between the guanidinium group and
the -lactam carboxylate is 6.2 Å, whereas a direct interaction
between these two groups is generally observed in acyl-enzyme
intermediates of class A -lactamases.
The R39 active site does not undergo a great structural
deformation upon -lactam binding. The main effect of acyla-
tion on the R39 structure is a slight tilt of the 3 strand and a
displacement of Thr413 (Fig. 2C). The side chain of Thr413
moves 2.35 Å in direction of nitrocefin, allowing for hydrogen
bond formation between the substrate carboxylate and the
hydroxyl groups of Thr411 and Thr413. The situation is identical
in all molecules except a slight difference in the position of the
nitrocefin C6 substituent and a consequent adaptation of the
side chain of residues Tyr147 and Met414.
Non Penicillin-binding Domains—Domain II (residues 66–
165 and 237–284) is a five-stranded -sheet with two helices
packed on one side (Fig. 3A). The sheet is composed of one
antiparallel and four parallel strands in the order 5II-1II-2II-
3II-4II with 1II anti-parallel. Strand 2II is followed by helix
1II, and strand 3II is followed by helix 2II. The topology as well
as the three-dimensional arrangement of the subdomain formed
by 2II-1II-3II-2II-4II corresponds to one-half of a Rossmann
fold. Using a three-dimensional DALI search (32) with residues
66–165 and 237–284, domain II was found to topologically re-
semble domains of E. coli d-Tyr-tRNATyr deacylase (33) (PDB
1JKE) and barley 1,3–1,4--glucanase (34) (PDB 1AQ0) with
Z-scores of 5.5 and 4.7, respectively. Indeed, the five strands and
the two helices can be superimposed with a root mean square
value of 3.1 Å for 82 aligned C atoms for the d-Tyr-tRNATyr
deacylase and 3.5 Å for 74 aligned C atoms for the 1,3–1,4--
glucanase. Domain II is also topologically similar to the N-termi-
nal domain of MinC (35) and the 1A region of FtsA (36), two
proteins interacting with FtsZ and involved in the regulation of
the septum formation in cell division. However the resemblance
between R39 and both MinC and FtsA remains limited. More-
over, R39 lacks sequence homology with all these topologically
similar proteins and the loops connecting the secondary struc-
tures are completely different.
A  hairpin connects strands 1II and 2II. Two arginines
FIG. 3. Structure of R39 domain II.
A, structural comparison of R39 domain
II, d-Tyr-tRNA deacylase, and the N-ter-
minal domain of MinC. Secondary struc-
tures of domain II are labeled; B, dipolar
head of R39 domain II. Nitrogen atoms
are colored blue; oxygen atoms are colored
red. Connections with the penicillin-bind-
ing domain and domain III are repre-
sented by small red spheres.
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(Arg81 and Arg82) constitute the head of the hairpin with their
side chain protruding out of the core of domain II. Similarly,
the side chains of Arg116 and Arg119, located in the loop con-
necting 1II and 3II, extend on the same side of domain II.
These four arginines, together with Lys261, form a positively
charged surface on the side opposite to the interface with the
penicillin-binding domain. The side chains of these residues
seem to float into the solvent. Accordingly, the temperature
factors of the side chains are high, and the electron density
around them is quite poor. A crown of negatively charged
residues (Glu76, Asp87, Asp121, Glu250, Glu251, Glu254, Asp263,
Asp272, Asp275, and Glu277) surrounds this positively charged
head (Fig. 3B). This dipolar surface might be involved in pro-
tein-protein interaction. On the opposite side, following 3II
strand, a long unstructured loop (126–153) extends out of do-
main II. It packs onto the penicillin-binding domain, with res-
idues Trp139, Asp142, and Tyr147 being part of a specific pocket
in the bottom of the active site. A small  hairpin connects this
loop to domain III.
Domain III consists of two three-stranded -sheets facing
each other in a kind of incomplete -barrel (Fig. 4). The first
-sheet is an antiparallel -sheet made of strands 2III-1III-
6III. The second -sheet consists of strands 3III-5III-4III,
5III being parallel to 3III and antiparallel to 4III. A DALI
search with residues 166–236 did not yield any structurally
similar protein (Z smaller than 2.5 and no equivalence with
visual inspection).
DISCUSSION
The Actinomadura R39 DD-peptidase is encoded by a 1614-
nucleotide gene. The 538-amino acid protein precursor pre-
sents a 49-amino acid N-terminal signal peptide and, presum-
ably, a 23-amino acid C-terminal extension that are both
cleaved to yield a mature soluble protein of 466 residues. When
the protein is produced in Streptomyces lividans TK24 grown in
YEME (Difco yeast extract, 3 g; Difco bactopeptone, 5 g; Oxoid
malt extract, 3 g; glucose, 10 g; sucrose, 340 g) medium, its
molecular mass is about 3 kDa higher than the molecular mass
exhibited by the protein purified from the culture supernatant
of Actinomadura R39. Moreover, the protein produced in
S. lividans lacks both DD-peptidase activity and penicillin-
binding ability. The mass difference associated with loss of
enzymatic activity was first thought to be an incorrect process-
ing of the signal peptide (8), but it might also result from an
incorrect processing of the C-terminal extension. A similar
situation has been observed with the R61 DD-peptidase, for
which the precursor containing the C-terminal extension was
shown to be inactive (37). Proteolytic cleavage of a C-terminal
fragment has been observed in few other cases, although not
necessarily associated with enzymatic activity (38–40). Inspec-
tion of the R39 three-dimensional structure reveals that the
C-terminal extension might reduce the active site accessibility
to peptide substrates or -lactam antibiotics, which would re-
sult in a loss of enzymatic activity and -lactam binding ability.
The mechanism of interaction between PBPs and -lactam
antibiotics is known to follow a three-step pathway involving
the rapid reversible formation of a non-convalent Henri-
Michaelis complex followed by formation of a long-lived acyl-
enzyme intermediate. Evidence supporting this mechanism is
given by the crystallographic structure of a non-covalent PBP-
-lactam complex described recently (28) and those of acyl-PBP
intermediates that have been solved with different PBPs (15,
16, 28–30). The possible acylation mechanism involved in R39
might be a general base-assisted catalytic process where the
role of the general base could be played by an unprotonated
lysine (Lys52 in R39), a residue strictly conserved in all PBPs.
Lys52 would abstract a proton from the active serine hydroxyl
group to promote the nucleophilic attack on the -lactam car-
bonyl by the activated serine O. The proton would subse-
quently be back donated by Lys52 to the -lactam nitrogen via
Ser298. The distances between Ser49 O and Lys52 N and
between Lys52 N and Ser298 O are, respectively, 2.8 and 2.98
Å, in agreement with this interpretation. In this case, the
unprotonated state of Lys52 can be promoted by the active site
environment and more precisely by the presence of Lys410. An
alternative interpretation of the acylation mechanism relies
upon a concerted one-step process where the covalent bond
formation between the -lactam and the active serine Ser49 is
concomitant with the transfer of the Ser49 proton directly to
Ser298 and to the transfer of the Ser298 hydroxyl proton to the
-lactam nitrogen (41). Charges on both Lys52 and Lys410 sup-
port the correct orientation of the Ser298 hydroxyl group. This
explanation could prevail for all penicilloyl serine transferases,
including enzymes possessing a tyrosine residue instead of a
serine in the second conserved active site motif, such as the
R61 DD-peptidase.
Compared with most other PBPs, R39 exhibits a very high
-lactam binding activity. The value of the second order acyla-
tion rate constant on benzylpenicillin is 300 mM1 s1 (i.e. the
highest value to date for a DD-peptidase) and the high k2/K
values obtained for other penicillins and cephalosporins ex-
plains the broad spectrum specificity profile of the R39 enzyme
(see Ref. 3 for detailed kinetic data on R39). Like class A
-lactamases and other low molecular mass PBPs (PBP5 and
K15), R39 presents a open active site capable of accommodating
most -lactam antibiotics. Many factors may impair the ability
of a PBP to bind -lactams. For example, in the highly resistant
Staphylococcus aureus PBP2a, there is a narrow binding cavity
(the distance between Asn300 O1 and Thr413 backbone nitro-
gen is 9 Å in R39, whereas this distance is 6.7 Å in the apo
structure of PBP2a). As a result, this cavity must be enlarged
to accommodate the incoming antibiotic and the active site
needs undergoing conformational changes at strand 3 and at
the helix 2 N terminus for acylation to occur (15). Modification
of active site catalytic residues may also reduce acylation rate
constants. In K15, the enzyme has a very poor -lactam binding
activity, because a cysteine, instead of an asparagine, is pres-
ent at the position equivalent to Asn300 (6). Nothing prevents
an efficient acylation of R39 by -lactams and if R39 is the best
FIG. 4. Structure of R39 domain III. The six -strands of domain
III are labeled. Connections with domain II are represented by small
red spheres.
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-lactam-binding DD-peptidase, this is due to the fact that the
active site of other PBPs are less accessible or lack the complete
set of amino acids involved in the acylation machinery.
The R39 active site structure is very similar to that of PBP5
(Fig. 5). The main difference that could explain the differences
between the -lactam acylation rates of these two enzymes is
the substitution of Thr413 by a histidine. Many acyl-PBP com-
plexes are stabilized by a hydrogen bond between this threo-
nine and the substrate carboxylate. The R39 active site is also
very similar to that of class A -lactamases. The similarity of
low molecular mass PBPs to class A -lactamases has been
previously pointed out (1, 4), and the presence, near the active
site, of Arg397, which is strictly conserved in class C low molec-
ular mass PBPs, suggests that both enzymes might have
evolved divergently from the same gene. Indeed, conforma-
tional changes in residues surrounding helix 10 may bring
Arg397 in a position equivalent to Arg220 in SaG. It has been
shown that this arginine favors acylation of class A -lacta-
mases by -lactam antibiotics thanks to a strong interaction
between the guanidinium group of arginine and the substrate
carboxylate (42). In R39, even if the distance between the
guanidinium and the carboxylate is more than 6 Å, Arg397
might influence the enzymatic activity, for example by inter-
acting with the C-terminal carboxylate of the peptide sub-
strate, as seen in the structure of the R61 DD-peptidase with
its peptide substrate (43). Alternatively, the Arg397 guani-
dinium group might interact with the complex side chain of a
meso-diaminopimelic acid residue and thus be linked to the
‘endopeptidase‘ activity of the enzyme. The exact role of this
residue can be addressed by site-directed mutagenesis.
The most distinctive feature of the R39 active site is the
pocket located in the bottom of the active site and formed by
residues Trp139, Asp142, Tyr147, Arg351, and Met414. Trp139,
Asp142, and Tyr147 belong to domain II, a unique domain only
found in class C PBPs. This pocket could be specific to accom-
modate the N-terminal portion of the diaminopimelic acid com-
ponent typical of the Actinomadura cell wall peptidoglycan. In
R61, such a specific subsite, different from the R39 one, has
been shown to be responsible for the high affinity of R61 for its
cell wall peptidoglycan (43).
As with most PBPs, the deacylation step in R39 is extremely
slow compared with the efficiency of the deacylation step in
class A -lactamases (a factor up to 108). In the latter a glu-
tamic acid of the -loop defining the bottom of the active site
(Glu166) activates a conserved water molecule that attacks the
acyl-enzyme carbonyl, resulting in very high deacylation rates.
In R39, the 343–353 loop in the bottom of the active site is
folded like its counterpart in PBP5 but lacks the conserved
Asp154 and His151 residues that have been hypothesized to be
responsible for the relatively high deacylation rate of PBP5
(44). The absence of residue capable of activating a deacylating
water molecule as well as the absence of such a deacylating
water molecule in the nitrocefin-R39 acyl-enzyme crystal struc-
ture would explain the poor deacylation rate of R39.
Low molecular mass PBPs exhibit a high carboxypeptidase
activity, but class C low molecular mass PBPs also have an
‘endopeptidase‘ activity that is generally not encountered in
other PBPs. Where and when class C low molecular mass PBPs
might require one of these enzymatic activities remains un-
clear, and their physiological role is still unknown. It has been
suggested that the endopeptidase activity of E. coli PBP4 is
involved in breaking peptide cross-links to allow the insertion
of new glycan strands into the murein sacculus (45). Recent
investigations have assigned a role to this PBP in determining
a uniform morphology thanks to the same activity, i.e. removal
of inappropriate cross-links initiated by PBP5. In vivo the
enzyme seems to behave as a DD-carboxypeptidase rather than
a transpeptidase (46, 47). In B. subtilis, it was shown that
PBP4a is expressed during the late exponential phase but is
dispensable for the synthesis of spore peptidoglycan (10, 48).
The structure of R39, with its two additional non-penicillin
binding domains, suggests that R39 and more generally class C
PBPs could be part of a proteic complex. The resemblance of the
R39 domain II topology with E. coli d-Tyr-tRNATyr deacylase
and barley 1,3–1,4--glucanase is astonishing but seems un-
likely to be associated with the functional properties of these
enzymes. Although B. subtilis PBP4a was shown to be absent
from the septum site (49), it is interesting that interactions
between proteins of the septation machinery and minor pepti-
doglycan-modifying enzymes have been shown to be responsi-
ble for significant aspects of bacterial shape determinations
(50). Although very limited, the resemblance of R39 domain II
to the N-terminal domain of MinC and the 1A region of FtsA,
two proteins involved in the regulation of septum formation,
suggests that class C low molecular mass PBPs could interact
with a protein of the septation machinery. The interacting
partner of domain II, if any, remains to be identified if one is to
understand the physiological importance of this element of
class C low molecular mass PBPs.
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